Caballero, Jhesrille P.

HRN: 22-35-66  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/14/2023
AMPICILLIN 500MG (VIAL)
10/14/2023
10/20/2023
IV
465mg
Q6h
PCAP C
Waiting Final Action 
10/14/2023
CEFTRIAXONE 1G (VIAL)
10/14/2023
10/20/2023
IV
800mg
OD
PCAP-severe
Waiting Final Action 
10/14/2023
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
10/14/2023
10/20/2023
IV
140mg
OD
PCAP-severe
Waiting Final Action 
10/16/2023
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
10/16/2023
10/23/2023
IV
470mg
Q6hours
PCAP-C
Waiting Final Action 
10/26/2023
MUPIROCIN 2%, 15G (TUBE)
10/26/2023
10/30/2023
APPLY ON SKIN
Thin Layer
BID
Skin Rashes
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

 Indication:

              

 Type of Infection:

                             

           

 Compliance to guidelines:



 Initial appropriateness:



 If inappropriate:

           

 Final appropriateness:



 If inappropriate:

              

 Overall appropriateness: